Novo Nordisk's pricing strategies inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price tag gouging, mentioning the stark contrast amongst U.S. rates and those in Europe and copyright. are scheduled to have surgical procedures